• Clinical Trials.gov is a service of the National Institutes of Health. The Website provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Search NIH's database of Federal and private studies taking place nationwide.


  • FDA's Office for Special Health Issues serves the public by answering questions about FDA activities related to HIV/AIDs, Cancer Information, Cancer Liaison Program, Patient Representative Program, and other special health issues.


  • FDA's Office of Orphan Products Development assists and encourages the identification, development, and availability of safe and effective products for people with rare diseases and disorders.


  • The National Center for Complementary and Alternative Medicine at NIH provides information about ongoing alternative medicines clinical trials sponsored by that center.


  • There are many more Websites with information about clinical trials both on the FDA Website and on other Government Websites, as well as on some education sites. See Web Sites of Interest for Good Clinical Practice and Clinical Trial Information.


  • Visit the OIG Website: The HHS Office of Inspector General conducts short-term management and program evaluations that focus on issues of concern to the Department, the Congress and the public relating to human subject protection and clinical trials. The following reports are available on their Website:


    • Clinical Trial Web Sites: A Promising Tool to Foster Informed Consent (OEI-01-97-00198 May 2002)


    • FDA Oversight of Clinical Investigators (OEI-05-99-00350 June 2000)


    • Institutional Review Boards: The Emergence of Independent Boards (OEI-01-97-00192 June 1998)


    • Institutional Review Boards: Their Role in Reviewing Approved Research (OEI-01-97-00190 June 1998)


    • Institutional Review Boards: A Time for Reform (OEI-01-97-00193 June 1998)


    • Institutional Review Boards: Promising Approaches (OEI-01-98-00191 June 1998)


    • Protecting Human Research Subjects: Status of Recommendations (OEI-01-97-00197 April 2000)


    • Recruiting Human Subjects: Pressures in Industry-Sponsored Clinical Research (OEI-01-97-00195 June 2000)


    • Recruiting Human Subjects: Sample Guidelines for Practice (OEI-01-97-00196 June 2000)


    • The Globalization of Clinical Trials: A Growing Challenge in Protecting Human Subjects (OEI-01-00-00190 September 2001)


  • Public Responsibility in Medicine and Research
    Membership in the Applied Research Ethics National Association (ARENA), the membership division of Public Responsibility in Medicine and Research (PRIM&R) is a cost effective way to stay informed about new regulations, agency news, educational events, and access to other educational resources related to human subjects research protections.


  • For more information on research repositories, databases and HIPAA privacy, go to:
    http://privacyruleandresearch.nih.gov/research_repositories.asp


  • CenterWatch
    A commercial site that lists Ct'S


  • ACRPNet
    A trade group's Web site


  • NIH Clinical Trials site
    A government Web site


  • Monitoring Related Links
    • http://www.fda.gov/cder/guidance/959fnl.pdf
    • http://www.fda.gov/oc/ohrt/irbs/default.htm
    • http://www.fda.gov/oc/gcp/regulations.html
    • http://www.fda.gov/ora/cpgm/default.htm